Healthcare - Biotechnology - NASDAQ - US
$ 4.31
-8.69 %
$ 304 M
Market Cap
-2.52
P/E
BALANCE SHEET
376 M
ASSETS
130 M
LIABILITIES
246 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
C4 Therapeutics, Inc.
| Current Assets | 271 M |
| Cash & Short-Term Investments | 254 M |
| Receivables | 11.8 M |
| Other Current Assets | 5.71 M |
| Non-Current Assets | 105 M |
| Long-Term Investments | 31.5 M |
| PP&E | 71.1 M |
| Other Non-Current Assets | 2.72 M |
| Current Liabilities | 42.8 M |
| Accounts Payable | 1.45 M |
| Short-Term Debt | 10.4 M |
| Other Current Liabilities | 30.9 M |
| Non-Current Liabilities | 87.6 M |
| Long-Term Debt | 132 M |
| Other Non-Current Liabilities | -43.9 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 126.6 | 29.8 | 76.1 | 181.7 | 90.5 | 36.3 |
| Short Term Investments | 127.1 | 246.4 | 233.2 | 190.0 | 0 | 0 |
| Receivables | 11.8 | 1.5 | 5.7 | 4.5 | 4.6 | 86.4 |
| Inventory | 0 | (61.0) | 0 | 0 | 1 | 1 |
| Other Current Assets | 5.7 | 9.9 | 21.4 | 9.7 | 3.2 | 0.8 |
| Total Current Assets | 271.2 | 287.6 | 325.7 | 381.0 | 96.8 | 123.5 |
| PP&E | 71.1 | 77.5 | 35.1 | 16.6 | 18.9 | 20.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 31.5 | 61.0 | 142.2 | 2.6 | 2.6 | 2.6 |
| Other Long Term Assets | 2.7 | 4.8 | 3.8 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 376.5 | 430.8 | 506.8 | 400.1 | 118.3 | 146.5 |
| LIABILITIES | ||||||
| Accounts Payable | 1.4 | 1.2 | 4.5 | 5.7 | 5.4 | 1.2 |
| Short Term Debt | 10.4 | 11.7 | 2.7 | 2.1 | 0.9 | 0.7 |
| Other Current Liabilities | 15.4 | 15.1 | 12.3 | 8.5 | 27.4 | 3.0 |
| Total Current Liabilities | 42.8 | 44.5 | 51.2 | 43.9 | 33.6 | 23.9 |
| Long Term Debt | 131.5 | 80.2 | 72.3 | 33.7 | 12.9 | 13.7 |
| Deferred Tax Income | 0 | 9.2 | 10.8 | 10.1 | 0 | (13.7) |
| Other Liabilities | (65.8) | 0 | (30.8) | (11.8) | 111.0 | 111.0 |
| Total Liabilities | 130.3 | 141.6 | 117.2 | 119.3 | 230.2 | 226.2 |
| EQUITY | ||||||
| Common Stock | 6 K | 5 K | 5 K | 4 K | 1 K | 1 K |
| Retained Earnings | (528.4) | (395.9) | (267.7) | (183.8) | (117.5) | (83.4) |
| Other Accumulative Comprehensive Income/Loss | (0.1) | (4.1) | (0.8) | 13 K | 1 K | (2.5) |
| Total Equity | 246.1 | 289.2 | 389.6 | 280.8 | (112.0) | (79.8) |
| Total Liabilities and Equity | 376.5 | 430.8 | 506.8 | 400.1 | 118.3 | 146.5 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 49.6 | 48.9 | 46.0 | 43.1 | 43.0 | 14.8 |